Baseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings.
about
Prevalence and correlates of cytopenias in HIV-infected adults initiating highly active antiretroviral therapy in Uganda.A review of the use of blood and blood products in HIV-infected patientsAntiretroviral treatment reverses HIV-associated anemia in rural TanzaniaAnemia and iron homeostasis in a cohort of HIV-infected patients in Indonesia.Laboratory and clinical predictors of disease progression following initiation of combination therapy in HIV-infected adults in ThailandVirologic versus immunologic monitoring and the rate of accumulated genotypic resistance to first-line antiretroviral drugs in Uganda.Evaluating the utility of early laboratory monitoring of antiretroviral-induced haematological and hepatic toxicity in HIV-infected persons in Cameroon.Resolution of anaemia in a cohort of HIV-infected patients with a high prevalence and incidence of tuberculosis receiving antiretroviral therapy in South Africa.Haemoglobin recovery among HIV-1 infected patients on zidovudine-based antiretroviral therapy and other regimens in north-central NigeriaPrevalence and correlates of anemia among HIV infected patients on highly active anti-retroviral therapy at Zewditu Memorial Hospital, EthiopiaAnemia and Red Blood Cell Abnormalities in HIV-Infected and HIV-Exposed Breastfed Infants: A Secondary Analysis of the Kisumu Breastfeeding Study.The impact of HIV-associated anaemia on the incidence of red blood cell transfusion: implications for blood services in HIV-endemic countries.Impact of highly active antiretroviral therapy on hematological indices among HIV-1 infected children at Kenyatta National Hospital-Kenya: retrospective studyIncreased risk of mortality and loss to follow-up among HIV-positive patients with oropharyngeal candidiasis and malnutrition before antiretroviral therapy initiation: a retrospective analysis from a large urban cohort in Johannesburg, South AfricaPredictors of Persistent Anaemia in the First Year of Antiretroviral Therapy: A Retrospective Cohort Study from Goma, the Democratic Republic of CongoPrevalence, severity, and related factors of anemia in HIV/AIDS patients.Immunology in Africa.Six-month hemoglobin concentration and its association with subsequent mortality among adults on antiretroviral therapy in Lusaka, ZambiaDevelopment of Severe Anemia and Changes in Hemoglobin in a Cohort of HIV-Infected Ugandan Adults Receiving Zidovudine-, Stavudine-, and Tenofovir-Containing Antiretroviral RegimensAnemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART RegimenAnaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS.Minimal impact of an iron-fortified lipid-based nutrient supplement on Hb and iron status: a randomised controlled trial in malnourished HIV-positive African adults starting antiretroviral therapy.
P2860
Q33417606-40CBDDD1-4BA3-4026-A019-66A9B8B28209Q33643448-85B9BED5-0511-44D2-A81F-3A27A9CB910DQ33957276-85AE2102-A532-4853-8B8C-6F671F6E12FDQ33986542-01DD2C3E-1CD3-4543-948D-85744AE0567DQ34385049-D3C3A4A6-E35F-4746-BFA1-2C54ABE5DDC7Q34523909-F037F3E8-2A38-481A-B9E5-DB3294E52C44Q34670487-19D7DA2C-982D-4834-84C1-C32A0EB2CE8BQ34988904-B13966C1-3DBE-4AC3-A037-C6DA0D930BA8Q35268378-11B5C7CE-1FD7-40A9-A2A9-06E05E15878EQ35653517-0A0D049A-F45C-4CB3-A345-64694FD98935Q35830556-99AC0FFE-F71B-4824-93EC-F85F41F1C586Q35915467-09B6FBE3-1B0E-48D7-AEF3-F8951921B384Q35957021-1286F7D4-D1C0-470E-9F2E-806EB2EB1CC1Q36018390-E7192FCC-667F-492D-A440-288A6C579043Q36170959-F356A206-89DA-4F79-A3F6-9AC64BA2E50CQ36474615-4E3593C6-023D-45B9-B19E-4E6CC7C39D3CQ36532554-7BB0423B-CEC1-4E2C-9487-9F6DC480BBF1Q36583316-AED24583-6FC1-4862-9369-6CD7B3F15035Q37094829-DC901797-DEBD-4460-80E8-B566B652D2EFQ37166538-15672FE8-D7E4-46AB-956F-EF4AA4E58616Q37182021-0B02DBBF-C379-473F-80B7-45DA9ED22826Q39100244-8B6C2747-7F91-4F5D-9448-A9062F868086
P2860
Baseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Baseline severe anaemia should ...... in resource-limited settings.
@ast
Baseline severe anaemia should ...... in resource-limited settings.
@en
Baseline severe anaemia should ...... in resource-limited settings.
@nl
type
label
Baseline severe anaemia should ...... in resource-limited settings.
@ast
Baseline severe anaemia should ...... in resource-limited settings.
@en
Baseline severe anaemia should ...... in resource-limited settings.
@nl
prefLabel
Baseline severe anaemia should ...... in resource-limited settings.
@ast
Baseline severe anaemia should ...... in resource-limited settings.
@en
Baseline severe anaemia should ...... in resource-limited settings.
@nl
P2860
P356
P1476
Baseline severe anaemia should ...... in resource-limited settings.
@en
P2093
Barbara Castelnuovo
Yukari C Manabe
P2860
P2888
P356
10.1186/1758-2652-13-42
P577
2010-11-03T00:00:00Z
P5875
P6179
1039279270